Search

Scholarly Works (1 results)

Article
Peer Reviewed

Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy.

Johnson, Kelly;
Okochi, Hideaki;
Arreguin, Mireya;
Watabe, Joseph;
Chattopadhyay, Anindita;
Imbert, Elizabeth;
Gandhi, Monica;
Spinelli, Matthew;
Glidden, David;
Hickey, Matthew

UC San Francisco Previously Published Works (2023)

We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59-20.14; P = .007). This suggests an existing point-of-care assay developed for tenofovir disoproxil fumarate will support adherence monitoring for patients on all TFV-based antiretrovirals.

Cover page: Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy.